InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 21.34
-0.70 (-3.18%)
At close: Apr 21, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 12.75 billion as of April 20, 2026. Its market cap has increased by 26.73% in one year.
Market Cap
12.75B
Enterprise Value
11.23B
Revenue
37.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.34
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 12.75B, an increase of 44.99%. That is a compound annual growth rate of 10.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 12.75B | -19.09% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 14.49B |
| Tibet Cheezheng Tibetan Medicine | 13.27B |
| Chengzhi | 12.97B |
| Vcanbio Cell & Gene Engineering Corp., | 12.91B |
| Pacific Shuanglin Bio-pharmacy | 12.27B |
| Hualan Biological Vaccine | 11.85B |
| Chengdu Olymvax Biopharmaceuticals | 11.81B |
| Chengdu Easton Biopharmaceuticals | 11.66B |